Lately, there have been numerous polls on social media going around asking if the Colorado Rockies‘ signing of Kris Bryant this past offseason is a bust. Due to Bryant’s ongoing stint on the injured list, that question is entirely unfair and way too early to make a determination.
Instead, these polls need to be asking the same question but about the offseason signing of Ryan McMahon to a six-year, $70 million contract extension.
Through 64 games, Ryan McMahon has quite possibly been the Rockies’ biggest disappointment this season. He is currently slashing .228/.320/.353 with only four home runs, 32 RBI, and 27 runs scored with 72 strikeouts in 224 at-bats. He also leads the majors in defensive errors with 11 and his fielding percentage is only .941.
Those numbers aren’t bad when compared to his month of June where he has hit a measly 10-for-56 (.179) with zero homers, 10 RBI, and 21 strikeouts (37.5 percent strikeout rate) including going 1-for-12 in the Cleveland Guardians’ sweep of the team this week. His struggles have coincided with the Rockies’ 5-11 record in the month.
Ryan McMahon has been a disappointment for the Colorado Rockies this season
Entering the season, many thought that Colorado Rockies infielder Ryan McMahon would finally take a step forward and enter the upper echelon of players in majors. He has the potential to hit 30-plus home runs and drive in 100 RBI. I even predicted at the start of the season that he would break Nolan Arenado’s Gold Glove streak, but that is obviously not going to happen.
At the rate he is going, McMahon is on pace for 15 homers and 70 RBI. Those are not the numbers the Rockies want from the middle of their order which is why he has found himself hitting as low as the seventh spot in the lineup as of late.
When he signed his extension, I questioned whether or not the Rockies it was too early as McMahon wouldn’t have become a free agent until after 2023 season.
Like Kris Bryant, the question as to whether McMahon’s signing is a bust is still a bit premature but so far the results have not been promising.